Clinical trial
An Open Label Treatment Extension Study of AMG 706
NCT00360867 · Amgen, Industry · Terminated
Key facts
| NCT number | NCT00360867 |
|---|---|
| Title | An Open Label Treatment Extension Study of AMG 706 |
| Official title | An Open Label Treatment Extension Study of AMG 706 |
| Lead sponsor | Amgen, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Solid Tumors |
| Intervention type | Drug |
| Interventions | AMG 706 |
| Enrollment | 94 |
| Start date | Dec 1, 2005 |
| Primary completion | Jul 1, 2012 |
| Completion | Jul 1, 2012 |
| First posted | Aug 7, 2006 |
| Last update posted | Oct 15, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: